• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI
Click for more information
0.00% 0.7¢

ALGORAE PHARMACEUTICALS LIMITED

Market Cap $11.81M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI)... Algorae Pharmaceuticals Limited is an Australia-based artificial-intelligence (AI) enabled drug discovery and development company. The Company is actively engaged in expanding its therapeutic pipeline using a proprietary artificial intelligence (AI) drug discovery and development platform, known as Algorae Operating System (AlgoraeOS). The AI platform leverages extensive medical and scientific databases from various disciplines within an advanced system at the intersection of AI and pharmaceutical research. By employing machine learning, deep learning, and neural networks, the AlgoraeOS is focused on uncovering synergistic fixed dose drug combinations that lead to the development of effective treatments for any medical condition. It is also focused on advancing its drug candidates, which include AI-116 for the treatment of neurodegenerative disorders and/or dementia, and AI-168 for cardiovascular disease and NTCELL for Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AI
Google's Quantum Chip 		22/12/24 4 2.3K
22/12/24 Last post  IAmShovel Comments Created with Sketch.  4  Views Created with Sketch.  2.3K 
1AI
Ann: 24 New AI-Generated Drug Targets 		16/12/24 15 6.6K
16/12/24 Last post  Leabeg Comments Created with Sketch.  15  Views Created with Sketch.  6.6K 
1AI
Ann: Significant Cardioprotection Qualities in AI-168 Studies 		02/12/24 12 4.5K
02/12/24 Last post  Telluride Comments Created with Sketch.  12  Views Created with Sketch.  4.5K 
1AI
Ann: Appointment of Pharmaceutical Executive 		28/11/24 2 906
28/11/24 Last post  Cambobro69 Comments Created with Sketch.  2  Views Created with Sketch.  906 
1AI
Ann: Proposed issue of securities - 1AI 		18/11/24 0 413
18/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  413 
1AI
Ann: Algorae Discontinues Legacy OTCQB AD Share Program 		18/11/24 0 356
18/11/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  356 
1AI
Ann: Quarterly Activities Report /Appendix 4C Cash Flow Statement 		17/11/24 6 3.2K
17/11/24 Last post  asxfighter Comments Created with Sketch.  6  Views Created with Sketch.  3.2K 
1AI
Ann: Appendix 3Y x2 		28/10/24 0 400
28/10/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  400 

See All Discussions arrow Created with Sketch.

Timeline

Significant Cardioprotection Qualities in AI-168 Studies
29 Nov 08:59
 
Appointment of Pharmaceutical Executive
28 Nov 08:56
 
24 New AI-Generated Drug Targets
21 Nov 09:08
 
Proposed issue of securities - 1AI
18 Nov 09:09
 
Algorae Discontinues Legacy OTCQB AD Share Program
18 Nov 09:02
 
Appendix 3Y x2
28 Oct 18:23
 
View More arrow Created with Sketch.

Featured News

NEWS Aussie Broadband Appoints Brian Maher as Group CEO
right-arrow Created with Sketch.
NEWS First Paediatric Patient Recruited for ACTION3 Phase 3 Clinical Trial
right-arrow Created with Sketch.
NEWS Spacetalk Reports Strong Growth with $11.0 Milllion ARR
right-arrow Created with Sketch.
NEWS Gold Mountain Uncovers Significant Lithium Anomalies at Salinas South, Brazil
right-arrow Created with Sketch.
NEWS Fifth Platform Lot testing completed, 4DS advances to next stage
right-arrow Created with Sketch.
NEWS Hydrology Drilling Kicks Off at Lo Herma
right-arrow Created with Sketch.
(20min delay)
Last
0.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.81M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $920 131.3K

Buyers (Bids)

No. Vol. Price($)
22 8746709 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 169762 1
View Market Depth
Last trade - 14.31pm 17/01/2025 (20 minute delay) ?
1AI (ASX) Chart

Top Stories

Lynas sales revenues up in Q2 of FY 2025, but lower production fuels share price slump

Lynas Rare Earths Ltd has seen its share price drop 5.5% after releasing quarterly activities report in which it noted lower production
ASX Market Open: Tech stocks pull US indexes lower, reflected in weak Aussie opening | January 17, 2025 The Australian market is set to open virtually flat today, weighed down by falls on all three US bourses, as major tech stocks were lower
Rio shares drop 1% on talk of Glencore merger Rio Tinto has been trading down on reports that the mining titan could be in merger discussions with Glencore.
Lunnon finds shallow and broad gold with quartz breccia structure at Lady Herial Lunnon Metals Ltd has rounded off its drilling program of 2024 will a series of diamond results which showed broad gold at shallow depths
HotCopper Highlights: Your most watched stocks for Week 3, 2025 Good afternoon and welcome back to HotCopper highlights for the third week of the year @ let’s get into it. Raiden Resources was by far the most viewed stock as long-awaited results from its WA lithium drilling campaign turned up a duster. The company expanded the program out of t...

Featured News

NEWS Strong Sales Growth for Travelan Immune Supplement Continues
right-arrow Created with Sketch.
NEWS Aussie Broadband Appoints Brian Maher as Group CEO
right-arrow Created with Sketch.
NEWS European Approval Granted for Prostate Cancer PET Imaging Agent Illuccix
right-arrow Created with Sketch.
NEWS Remote Medical Image Aggregation Proves Successful, Moves to Phase 2
right-arrow Created with Sketch.
NEWS Drilling Ramp-Up at White Devil Gold Project as Exploration Continues
right-arrow Created with Sketch.
NEWS Fifth Platform Lot testing completed, 4DS advances to next stage
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.